Published 12 hours ago • loading... • Updated 9 hours ago

ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit

Summary by SRI News

NEW YORK, March 29, 2026 /PRNewswire/ -

+4 Reposted by 4 other sources

9 hours ago

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources5

Leaning Left0Leaning Right0Center3Last Updated4 minutes agoBias Distribution

100% Center

100% Center

Untracked bias

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

PR Newswire broke the news in United States 9 hours ago on Sunday, March 29, 2026.

Sources are mostly out of (0)

The lawsuit alleges Atara overstated regulatory approval chances and concealed manufacturing issues that increased FDA scrutiny, harming investors during the class period.